$3.11
-0.12 (-3.72%)
Open$3.15
Previous Close$3.23
Day High$3.24
Day Low$2.97
52W High$209.03
52W Low$2.29
Volume—
Avg Volume3.26M
Market Cap2.47M
P/E Ratio—
EPS$-294.14
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.87M | 6.22M | 707.3K |
| Net Income | -508,163,820 | -990,358,245 | 94.3K |
| Profit Margin | -17,689.8% | -16,805.4% | 13.3% |
| EBITDA | -532,016,148 | -1,094,446,385 | 212.4K |
| Free Cash Flow | — | — | 76.9K |
| Rev Growth | -53.8% | -53.8% | +7.8% |
| Debt/Equity | 0.08 | 0.08 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |